Publications by authors named "Gordon Cook"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

117

Total Likes

80

Extended Reach

242,786

Social Features

43
C
Challenging the concept of functional high-risk myeloma through transcriptional and genetic profiling.
Sina A Beer, David A Cairns, Charlotte Pawlyn, Amy Holroyd, Elsa Ferris, Gordon Cook

Blood· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Outcomes of Transplant Ineligible Older Adults With Multiple Myeloma Treated With Novel Regimens: A Population-Based Retrospective Cohort Study.
Nadine Abdallah, Hira Mian, Hsien Seow, Gregory P Pond, Anastasia Gayowsky, Gordon Cook

Am J Hematol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment and treatment of frail patients living with multiple myeloma. A guideline on behalf of the UK Myeloma Research Alliance Frailty Group.
Sally Moore, Hannah Miller, Christopher Parrish, Frances Seymour, Laura Miller, Gordon Cook

Br J Haematol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
COVID-19-related mortality in a real-world cohort of 18 883 patients with premalignant and malignant haematological neoplasms: An analysis from the UK's Haematological Malignancy Research Network.
Alexandra Smith, Clare Frobisher, Abraham Varghese, Andy Rawstron, Simon Crouch, Gordon Cook

Br J Haematol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Machine learning risk stratification strategy for multiple myeloma: Insights from the EMN-HARMONY Alliance platform.
Adrian Mosquera Orgueira, Marta Sonia Gonzalez Perez, Mattia D'Agostino, David A Cairns, Alessandra Larocca, Gordon Cook

Hemasphere· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Post-Market Economic Evaluation of Bortezomib, Lenalidomide and Dexamethasone Versus Pre-funding Standard of Care for Newly Diagnosed Multiple Myeloma Using Registry Data.
Adam Irving, Dennis Petrie, Anthony Harris, Laura Fanning, Erica M Wood, Gordon Cook

Pharmacoeconomics· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Doubling in median survival in patients diagnosed with multiple myeloma 2005-2019; a real-world study from the UK's Haematological Malignancy Research Network.
Alexandra Smith, Timothy Bagguley, Eve Roman, Simon Crouch, Russell Patmore, Gordon Cook

Haematologica· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EHA-EMN Evidence-Based Guidelines for diagnosis, treatment and follow-up of patients with multiple myeloma.
Meletios A Dimopoulos, Evangelos Terpos, Mario Boccadoro, Philippe Moreau, María-Victoria Mateos, Gordon Cook

Nat Rev Clin Oncol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advance care planning in haematological malignancies: A qualitative exploratory analysis of the facilitators and barriers to implementing advance care planning in practice.
Jenna Tate, Christopher Parrish, Anjum Khan, Gordon Cook

Palliat Support Care· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An open-source repository-based tool for quality control of imaging protocol compliance: demonstration in a multicentre MRI study.
Sam Keaveney, Damien J McHugh, Mihaela Rata, Alina Dragan, Jessica M Winfield, Gordon Cook

Br J Radiol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Symptomatic progression-free survival as an emerging patient-centered endpoint in multiple myeloma: a secondary analysis of MagnetsiMM-3 trial data.
Martin Kortüm, Sebastian Theurich, James Farrell, Graham Jackson, Gordon Cook

BMC Cancer· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevention and treatment of venous thromboembolism in patients with multiple myeloma: Clinical practice guidelines on behalf of the European Myeloma Network.
Grigoris Gerotziafas, Despina Fotiou, Inger Nijhof, Cihan Ay, Ramon Lecumberri, Gordon Cook

Hemasphere· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Daratumumab/lenalidomide/dexamethasone in transplant-ineligible newly diagnosed myeloma: MAIA long-term outcomes.
Thierry Facon, Philippe Moreau, Katja Weisel, Hartmut Goldschmidt, Saad Z Usmani, Gordon Cook

Leukemia· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Artificial intelligence methods applied to longitudinal data from electronic health records for prediction of cancer: a scoping review.
Victoria Moglia, Owen Johnson, Gordon Cook, Marc de Kamps, Lesley Smith

BMC Med Res Methodol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Automated extraction of body composition metrics from abdominal CT or MR imaging: A scoping review.
Christopher Winder, Matthew Clark, Russell Frood, Lesley Smith, Andrew Bulpitt, Gordon Cook

Eur J Radiol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Greater preservation of SARS-CoV-2 neutralising antibody responses following the ChAdOx1-S (AZD1222) vaccine compared with mRNA vaccines in haematopoietic cell transplant recipients.
Hayley Colton, Natalie Barratt, Nigel Temperton, Hailey Hornsby, Adrienn Angyal, Gordon Cook

Br J Haematol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The UK consensus supporting effective introduction of novel treatments for multiple myeloma in the National Health Service.
Rakesh Popat, Supratik Basu, Sarah Henshaw, Kamaraj Karunanithi, Karthik Ramasamy, Gordon Cook

EJHaem· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Ixazomib as consolidation and maintenance versus observation in patients with relapsed multiple myeloma eligible for salvage autologous stem-cell transplantation (Myeloma XII [ACCoRD]): interim analysis of a multicentre, open-label, randomised, phase 3 trial.
Gordon Cook, A John Ashcroft, Ethan Senior, Catherine Olivier, Anna Hockaday, Mark Cook

Lancet Haematol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Developing and validating a discrete-event simulation model of multiple myeloma disease outcomes and treatment pathways using a national clinical registry.
Adam Irving, Dennis Petrie, Anthony Harris, Laura Fanning, Erica M Wood, Gordon Cook

PLoS One· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
UK Stakeholder Perspectives on Surrogate Endpoints in Cancer, and the Potential for UK Real-World Datasets to Validate Their Use in Decision-Making.
David Baldwin, Jonathan Carmichael, Gordon Cook, Neal Navani, James Peach

Cancer Manag Res· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Longitudinal dynamics and clinically available predictors of poor response to COVID-19 vaccination in multiple myeloma.
Gaurav Agarwal, Sally Moore, Ross Sadler, Sherin Varghese, Alison Turner, Gordon Cook

Haematologica· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity of third dose COVID-19 vaccine strategies in patients who are immunocompromised with suboptimal immunity following two doses (OCTAVE-DUO): an open-label, multicentre, randomised, controlled, phase 3 trial.
Carl S Goodyear, Amit Patel, Eleanor Barnes, Michelle Willicombe, Stefan Siebert, Gordon Cook

Lancet Rheumatol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of minimal residual disease (MRD) in salvage autologous stem cell transplantation for relapsed myeloma: results from the NCRI Myeloma X (intensive) trial.
Ruth M de Tute, Gordon Cook, David A Cairns, Julia M Brown, Jamie Cavenagh

Bone Marrow Transplant· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis